Previous 10 | Next 10 |
MISONIX (NASDAQ: MSON ): Q3 GAAP EPS of -$0.34 misses by $0.02 . More news on: Misonix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
FARMINGDALE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financi...
FARMINGDALE, N.Y., May 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today th...
Following objections over large publicly traded companies getting forgivable loans under the Payroll Protection Program, the U.S. Treasury issues new guidance explaining that the program is meant for companies with little access to other sources of capital, not for publicly traded companie...
Even with the U.S. Senate set to vote later today on passing an additional relief bill for small businesses in the U.S., there is a bright spotlight being thrown on where the funds from the original Paycheck Protection Program designed for small business went. More news on: Legacy Housing ...
Misonix ( MSON -0.4% ) reports preliminary Q3 2020 of ~$17.9M, up 86% Y/Y primarily led by Solsys Medical (including TheraSkin) acquisition; on pro-forma basis, sales were up 8.1% sequentially and 15.7% Y/Y. More news on: Misonix, Inc., Earnings news and commentary, Healthcar...
With Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE, N.Y., April 02, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MS...
FARMINGDALE, N.Y., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participati...
Image source: The Motley Fool. Misonix Inc (NASDAQ: MSON) Q2 2020 Earnings Call Feb 5, 2020 , 4:30 p.m. ET Operator Continue reading
Misonix, Inc. (MSON) Q2 2020 Earnings Conference Call February 05, 2020 4:30 PM ET Company Participants Norberto Aja - Investor Relations Stavros Vizirgianakis - President & Chief Executive Officer Joe Dwyer - Chief Financial Officer Conference Call Participants Alex No...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the “Election Deadline...
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...